Platelet reserve of Epidermal Growth Factor: approach to a possible emerging concept
Palabras clave:
blood platelets, epidermal growth factor, serum.Resumen
Introduction: Epidermal growth factor precursor is immersed in the context to Platelets membrane. The regular procedure to obtain serum implies a barrier to biological understanding of the theoretical meaning of its values. Objective: To describe the effect to modified procedure to measure sample epidermal growth factors and the possible biological implications for this. Method: An in vitro experimental study was carried put, with blood samples from individuals with apparent health history, in adulthood. Serum epidermal growth factor precursor values were determined with the UMELISA-EGF kit recommended by the manufacturer; the experimental variation in sample collection was carried out according to SAMERSAC recommendations for platelet-rich plasma, with adjustments. Results: The average age was 45.89± 3.35 years, in a range of 27 to 62 years. The female sex predominates in a 1.8:1 ratio. Application of the experimental procedure showed significant and notable differences between the epidermal growth factor values (g=17.7; p=0.0001-23); no linear correlation was evident between the values (r= 0.1305; p= 0.6843). The "reserve" value was on average 1498.61 ±160.68 pg*mL-1, observing large effect differences, as well as a similar behavior to a transition value. The observed data suggest, a posteriori, consumption effect on the course of platelet lysis under standard conditions. Conclusions: Epidermal growth factor values are higher after platelet isolation; the existence of an intraplatelet reserve of epidermal growth factor is plausible.Descargas
Citas
2. Burgess AW. Regulation of Signaling from the Epidermal Growth Factor Family. J. Phys. Chem. B. 2022;126(39):7475-85.
3. Kiso Farnè K, Tsuruyama T. Epidermal growth factor receptor cascade prioritizes the maximization of signal transduction. Sci Rep. 2022 [cited 20/11/2023];12(18950):1-9. Available from: https://www.nature.com/articles/s41598-022-20663-0.pdf
4. Shin SH, Koh YG, Lee WG, Seok J, Park KY. The use of epidermal growth factor in dermatological practice. Int Wound J. 2023 [cited 10/01/2024];20:2414-23. Available from: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/iwj.14075?download=true
5. Wu M, Ruan J, Zhong B. [Progress in human epidermal growth factor research]. Sheng Wu Gong Cheng Xue Bao. 2020 [cited 20/11/2023];36(12):2813-23. Available from: https://pubmed.ncbi.nlm.nih.gov/33398974/
6. Custo S, Baron B, Felice A, Seria E. A comparative profile of total protein and six angiogenically-active growth factors in three platelet products. GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW. 2022 [cited 25/09/2023];11:1-10. Available from: https://www.egms.de/static/pdf/journals/iprs/2022-11/iprs000167.pdf
7. González Pérez I, Castells Martínez EM, Cáceres Lavernia HH, León Monzón K. EGF sérico normalizado por plaquetas: metodología para su estimación y evaluación como biomarcador en cáncer. Cuba Salud IV Convención Internacional de Salud 17-21 de octubre, 2022 [cited 25/09/2023]. Available from: https://convencionsalud.sld.cu/index.php/convencionsalud22/2022/paper/viewFile/1410/1624
8. Kim BW, Kim SK, Heo KW, Bae KB, Jeong KH, Lee SH, et al. Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population. Renal Failure 2020 [cited 25/09/2023];42(1):98-106. Available from: https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2019.1710535?download=true
9. Hernández Bernal F, Estenoz García D, Gutiérrez Ronquillo JH, Martín Bauta Y, Catasús Álvarez K, Gutiérrez Castillo M, et al. Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial. Front. Neurol. 2024 [cited 15/01/2024];15:1303. Available from: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1303402/pdf?isPublishedV2=false
10. Pérez Hernández HJ. Presumptive implications of epidermal growth factors in inflammation. Rev. Cuban. Reumatol. 2024 [cited 20/11/2023]; 26:e1282. Available from: https://dialnet.unirioja.es/descarga/articulo/9451842.pdf
11. Ali Pérez NA, Robinson Rodríguez RJ, Hernández Ramírez P. Nueva tecnología sanitaria para el desarrollo de la medicina regenerative en Santiago de Cuba. Rev. Cubana Hematol. Inmunol. Hemoter. 2019 [cited 20/11/2023];35(3):a_934. Available from: http://scielo.sld.cu/pdf/hih/v35n3/1561-2996-hih-35-03-e934.pdf
12. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc National Acad Sci. April 9, 2004 [cited 20/11/2023];101(16):6062-7. Available from: https://www.pnas.org/doi/10.1073/pnas.0400782101?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed#tab-citations
13. Kjær IM, Olsen DA, Brandslund I, Bechmann T, Jakobsen EH, Bogh SB, et al. Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer. Sci Rep. 2020 [cited 20/11/2023];10:16558. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538553/pdf/41598_2020_Article_72944.pdf
14. Isono T, Hirayama S, Domon H, Maekawa T, Tamura H, Hiyoshi T, et al. Degradation of EGFR on lung epithelial cells by neutrophil elastase contributes to the aggravation of pneumococcal pneumonia. J Biol Chem. 2023 [cited 15/01/2024];299(6):104760. Available from: https://www.jbc.org/action/showPdf?pii=S0021-9258%2823%2901788-X
15. Saumell Esnaola M, Delgado D, García del Caño G, Beitia M, Sallés J, González Burguera I, et al. Isolation of Platelet-Derived Exosomes from Human Platelet-Rich Plasma: Biochemical and Morphological Characterization. Int J Mol Sci. 2022 [cited 20/11/2023];23(5):2861. Available from: https://mdpi-res.com/d_attachment/ijms/ijms-23-02861/article_deploy/ijms-23-02861-v2.pdf?version=1646721460
16. Nexø E, Jørgensen PE, Hansen MR. Human epidermal growth factor-on molecular forms present in urine and blood. Regul Pept. 1992;42(1-2):75-84.
17. González Perez I, Cáceres Lavernia HH, Carr Pérez A, León Monzón K. Measurement of Serum EGF Levels, a Methodological Approach: Learning What Means "Low-/High-Concentration of EGF In Serum". Some Clinical Implications. J Mol Biomark Diagn. 2017 [cited 20/11/2023];8(3):1000335. Available from: https://www.researchgate.net/publication/317687341_Measurement_of_Serum_EGF_Levels_a_Methodological_Approach_Learning_What_Means_Low-High-Concentration_of_EGF_In_Serum_Some_Clinical_Implications
18. Savage AP, Chatterjee VK, Gregory H, Bloom SR. Epidermal growth factor in blood. Regul Pept. 1986;16(3-4):199-206.
19. Cortvrindt C, Speeckaert R, Delanghe JR, Speeckaert MM. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease. Am J Nephrol. 2022 [cited 20/11/2023];53(5):372-87. Available from: https://karger.com/ajn/article/53/5/372/827403/Urinary-Epidermal-Growth-Factor-A-Promising-Next
20. Wu L, Li XQ, Chang DY, Zhang H, Li JJ, Wu SL, et al. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease. Nephrol Dial Transplant 2020 [cited 20/11/2023];35(2):291-7. Available from: https://watermark.silverchair.com/gfy314.pdf
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta revista provee acceso libre e inmediato a su contenido bajo el principio de que hacer disponible gratuitamente investigación al público, apoya aún más el intercambio de conocimiento global. Esto significa que los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la licencia internacional Creative Commons Atribución 4.0 que permite copiar y redistribuir el material en cualquier medio o formato para cualquier propósito, incluso comercialmente, además de remezclar, transformar y construir a partir del material para cualquier propósito.